Literature DB >> 16649214

The extracellular matrix in oral squamous cell carcinoma: friend or foe?

Amy F Ziober1, Erica M Falls, Barry L Ziober.   

Abstract

Oral squamous cell carcinoma is a disfiguring, highly invasive and metastatic cancer. Despite advances in detection and therapy, many patients will continue to face a poor prognosis. It is well established that the predominate factor determining overall survival in patients with oral squamous cell carcinoma is lymph node involvement. Tumor growth and progression to invasive cancer requires tumor cell interactions with the extracellular matrix. An understanding of how the extracellular matrix influences tumor development and invasion is fundamental in the development of new prognostic indicators and treatment strategies for oral squamous cell carcinoma. In this review, we summarize how changes in the extracellular matrix contribute to oral cancer development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16649214     DOI: 10.1002/hed.20382

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  19 in total

1.  Dendritic Cells (DC) Facilitate Detachment of Squamous Carcinoma Cells (SCC), While SCC Promote an Immature CD16(+) DC Phenotype and Control DC Migration.

Authors:  Lalitha V Ramanathapuram; Dustin Hopkin; Zoya B Kurago
Journal:  Cancer Microenviron       Date:  2011-08-02

2.  The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor-endothelial cell interactions.

Authors:  Maryam Rezaei; Jiahui Cao; Katrin Friedrich; Björn Kemper; Oliver Brendel; Marianne Grosser; Manuela Adrian; Gustavo Baretton; Georg Breier; Hans-Joachim Schnittler
Journal:  Histochem Cell Biol       Date:  2017-11-15       Impact factor: 4.304

3.  The 3D tissue microenvironment modulates DNA methylation and E-cadherin expression in squamous cell carcinoma.

Authors:  Teresa M DesRochers; Yulia Shamis; Addy Alt-Holland; Yasusei Kudo; Takashi Takata; Guangwen Wang; Laurie Jackson-Grusby; Jonathan A Garlick
Journal:  Epigenetics       Date:  2012-01-01       Impact factor: 4.528

4.  Gene Expression Signatures of Lymph Node Metastasis in Oral Cancer: Molecular Characteristics and Clinical Significances.

Authors:  Xiqiang Liu; Antonia Kolokythas; Jianguang Wang; Hongzhang Huang; Xiaofeng Zhou
Journal:  Curr Cancer Ther Rev       Date:  2010-11-01

5.  Regulation of cell migration via the EGFR signaling pathway in oral squamous cell carcinoma cells.

Authors:  Yuichi Ohnishi; Hiroki Yasui; Kenji Kakudo; Masami Nozaki
Journal:  Oncol Lett       Date:  2016-12-14       Impact factor: 2.967

6.  Galectin-7 promotes the invasiveness of human oral squamous cell carcinoma cells via activation of ERK and JNK signaling.

Authors:  Jia-Ping Guo; Xiao-Guang Li
Journal:  Oncol Lett       Date:  2017-01-25       Impact factor: 2.967

7.  Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.

Authors:  Muzafar A Macha; Nissar A Wani; Rais A Ganai; Ajaz A Bhat; Abid Hamid; Sheema Hashem; Mohammad Haris; Sham S Chauhan; Mohammad A Zargar; Surinder K Batra
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  A decreased ratio of laminin-332 beta3 to gamma2 subunit mRNA is associated with poor prognosis in colon cancer.

Authors:  Cherise M Guess; Bonnie J Lafleur; Brandy L Weidow; Vito Quaranta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

9.  Examination of oral cancer biomarkers by tissue microarray analysis.

Authors:  Peter Choi; C Diana Jordan; Eduardo Mendez; John Houck; Bevan Yueh; D Gregory Farwell; Neal Futran; Chu Chen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-05

10.  Epithelial-mesenchymal transition downregulates laminin alpha5 chain and upregulates laminin alpha4 chain in oral squamous carcinoma cells.

Authors:  Minna Takkunen; Mari Ainola; Noora Vainionpää; Reidar Grenman; Manuel Patarroyo; Antonio García de Herreros; Yrjö T Konttinen; Ismo Virtanen
Journal:  Histochem Cell Biol       Date:  2008-05-22       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.